ChromaDex Corporation (CDXC) NASDAQ

7.87

-0.07(-0.88%)

Updated at March 18 04:00PM

Currency In USD

ChromaDex Corporation

Address

10900 Wilshire Boulevard

Los Angeles, CA 90024

United States of America

Phone

310 388 6706

Sector

Healthcare

Industry

Biotechnology

Employees

104

First IPO Date

June 25, 2008

Key Executives

NameTitlePayYear Born
Robert N. FriedChief Executive Officer & Director768,9571960
Frank Louis Jaksch Jr.Co-Founder & Chairman70,0001968
Alex WorshamVice President of Global Marketing & Communications0N/A
Andrew ShaoSenior Vice President of Global Regulatory & Scientific Affairs0N/A
Kendall KnyschHead of Media Relations & Partnerships0N/A
Carlos LopezSenior Vice President & General Counsel0N/A
James LeeController01975
Ozan PamirChief Financial Officer & Principal Accounting Officer01992
Chu YanManaging Director of Asia Pacific0N/A
Michiko KelleyChief Marketing Officer0N/A

Description

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.